Study reveals effective combination therapy to slow cognitive decline in older adults

An important new study led by the Centre for Addiction and Mental Health (CAMH), and with partnership across several Toronto Dementia Research Alliance (TDRA) sites-; Baycrest, Sunnybrook Health Science Centre, Unity Health Toronto, and University Health Network-; has demonstrated that a combination therapy can slow cognitive decline in older adults at risk for dementia.

‘Wonderful Christmas gift’: Fed’s surprise rate-cut plan springs hope of 2024 biotech market rebound

Though Christmas is right around the corner, the long biotech winter may soon be over. The Federal Reserve announced Wednesday it plans to cut interest

December 15, 2023

Seagen positions Tukysa combo as option for breast cancer patients with brain metastases

The combination of Seagen’s Tukysa and Roche’s Kadcyla cut the risk of disease progression or death by 36% in HER2-positive breast cancer patients with brain

December 7, 2023

New liquid biopsy technology uses RNA “dark matter” to detect cancer

Cancer is most treatable in its early stages, so finding innovative and non-invasive methods to diagnose cancer early on is crucial for fighting the disease.

August 31, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.